Presence of Smartphone Cuts Available Cognitive Capacity

This article originally appeared here.
Share this content:
Presence of Smartphone Cuts Available Cognitive Capacity
Presence of Smartphone Cuts Available Cognitive Capacity

WEDNESDAY, June 28, 2017 (HealthDay News) -- Just the presence of one's smartphone is associated with reduced available cognitive capacity, according to a study published recently in the Journal of the Association for Consumer Research.

Noting that smartphones have immense potential to improve welfare, Adrian F. Ward, Ph.D., from the University of Texas at Austin, and colleagues examined the cognitive impact of smartphones. They tested the "brain-drain" hypothesis: that the presence of one's smartphone occupies limited-capacity cognitive resources, thereby undercutting cognitive performance.

Based on results of two experiments, the researchers found that even when people were successful at maintaining sustained attention by avoiding the temptation to check their phones, the presence of the devices was associated with a reduction in cognitive capacity. These cognitive costs were highest for those with the highest dependence on smartphones. This smartphone-induced brain drain can have practical implications for decision-making and consumer welfare.

"Our data suggest that the mere presence of consumers' own smartphones may further constrain their already limited cognitive capacity by taxing the attentional resources that reside at the core of both working memory capacity and fluid intelligence," the authors write. "Because consumers' smartphones are so frequently present, the mere presence effects observed in our experiments have the potential to influence consumer welfare across a wide range of contexts."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

FDA Approves New Treatment for Acute Lymphoblastic Leukemia

For patients with relapsed or refractory B-cell ALL who have received one or two prior treatments

Online Nursing Education Can Up Patient Use of VTE Prophylaxis

Online Nursing Education Can Up Patient Use of ...

Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism

On-Pump CABG Leads to Higher Rates of Five-Year Survival

On-Pump CABG Leads to Higher Rates of Five-Year ...

Study compared coronary-artery bypass grafting surgery, with/without cardiopulmonary bypass

is free, fast, and customized just for you!

Already a member?

Sign In Now »